ABN AMRO Investment Solutions’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-62,277
Closed -$981K 572
2025
Q3
$981K Sell
62,277
-1,638
-3% -$27K 0.02% 296
2025
Q2
$962K Hold
63,915
0.02% 299
2025
Q1
$961K Sell
63,915
-1,591
-2% -$23.5K 0.02% 292
2024
Q4
$944K Sell
65,506
-1,190
-2% -$21.3K 0.02% 310
2024
Q3
$1.3M Buy
66,696
+29,684
+80% +$537K 0.02% 290
2024
Q2
$634K Sell
37,012
-24,463
-40% -$451K 0.01% 356
2024
Q1
$1.03M Buy
61,475
+18,579
+43% +$282K 0.02% 299
2023
Q4
$777K Sell
42,896
-64,345
-60% -$1.17M 0.01% 309
2023
Q3
$1.82M Sell
107,241
-220
-0.2% -$3.15K 0.04% 254
2023
Q2
$1.29M Buy
107,461
+7,757
+8% +$106K 0.03% 272
2023
Q1
$1.3M Buy
+99,704
New +$1.63M 0.03% 281

Other funds holding HCM

ABN AMRO Investment Solutions's HCM Position: Q4 2025 in Review

ABN AMRO Investment Solutions sold out of HUTCHMED (HCM) in Q4 2025, closing a stake of 62,277 shares — an estimated $981K sold.

ABN AMRO Investment Solutions first reported a position in HCM in Q1 2023 and held it in 11 quarters. The position peaked at $1.82M in Q3 2023. 50 funds tracked by Wall St. Rank hold HCM as of Q4 2025.

  • ABN AMRO Investment Solutions reported no remaining HUTCHMED position as of Q4 2025 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 62,277 HUTCHMED shares in Q4 2025, an estimated $981K.
  • ABN AMRO Investment Solutions first reported a position in HUTCHMED in Q1 2023 and held it in 11 quarters.
  • ABN AMRO Investment Solutions's HUTCHMED position peaked at $1.82M in Q3 2023.
  • 50 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2025.

Based on ABN AMRO Investment Solutions's 13F filing for Q4 2025, filed 6 Feb 2026.